Efficacy profiles of antimicrobials evaluated against Staphylococcus species isolated from canine clinical specimens

dc.contributor.authorQekwana, Daniel Nenene
dc.contributor.authorOdoi, Agricola
dc.contributor.authorOguttu, James Wabwire
dc.contributor.emailnenene.qekwana@up.ac.zaen_ZA
dc.date.accessioned2022-02-01T09:56:08Z
dc.date.available2022-02-01T09:56:08Z
dc.date.issued2021-11-12
dc.description.abstractCross-resistance occurs between antimicrobials with either similar mechanisms of action and/or similar chemical structures, or even between unrelated antimicrobials. This study employed a multivariate approach to investigate the associations between the efficacy profile of antimicrobials and the clustering of eleven different antimicrobial agents based on their efficacy profile. Records of the susceptibility of 382 confirmed Staphylococcus species isolates against 15 antimicrobials based on the disc diffusion method were included in this study. Tetrachoric correlation coefficients were computed to assess the correlations of antimicrobial efficacy profiles against Staphylococcus aureus. Principal components analysis and factor analysis were used to assess the clustering of antimicrobial susceptibility profiles. Strong correlations were observed among aminoglycosides, penicillins, fluroquinolones, and lincosamides. Three main factors were extracted, with Factor 1 dominated by the susceptibility profile of enrofloxacin (factor loading (FL) = 0.859), gentamicin (FL = 0.898), tylosin (FL = 0.801), and ampicillin (FL = 0.813). Factor 2, on the other hand, was dominated by the susceptibility profile of clindamycin (FL = 0.927) and lincomycin-spectinomycin (FL = 0.848) and co-trimazole (FL = 0.693). Lastly, Factor 3 was dominated by the susceptibility profile of amoxicillin-clavulanic acid (FL = 0.848) and cephalothin (FL = 0.824). Antimicrobials belonging to the same category or class of antimicrobial, tended to exhibit similar efficacy profiles, therefore, laboratories must choose only one of the antimicrobials in each group to help reduce the cost of antimicrobial susceptibility tests.en_ZA
dc.description.departmentParaclinical Sciencesen_ZA
dc.description.librarianam2022en_ZA
dc.description.urihttps://www.mdpi.com/journal/animalsen_ZA
dc.identifier.citationQekwana, D.N.; Odoi, A.; Oguttu, J.W. Efficacy Profiles of Antimicrobials Evaluated against Staphylococcus Species Isolated from Canine Clinical Specimens. Animals 2021, 11, 3232. https://DOI.org/10.3390/ani11113232.en_ZA
dc.identifier.issn2076-2615
dc.identifier.other10.3390/ani11113232
dc.identifier.urihttp://hdl.handle.net/2263/83555
dc.language.isoenen_ZA
dc.publisherMDPIen_ZA
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_ZA
dc.subjectEfficacyen_ZA
dc.subjectStaphylococcusen_ZA
dc.subjectFactor analysisen_ZA
dc.subjectEigenvaluesen_ZA
dc.subjectPrincipal components analysis (PCA)en_ZA
dc.subjectAntimicrobial resistance (AMR)en_ZA
dc.titleEfficacy profiles of antimicrobials evaluated against Staphylococcus species isolated from canine clinical specimensen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Qekwana_Efficacy_2021.pdf
Size:
428.52 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: